NCAPG and central nervous system cancer: Overall, we can conclude that the expression of NCAPG in glioma is relatively high, and that the expression of MHC-I molecules and ADAM17 in glioma cells is also elevated, thereby inhibiting the activation of NK cells, resulting in immune escape and decreased patient survival.